HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.
Nucleoside analogs (NAs) are used to treat numerous viral infections and cancer. They compete with endogenous nucleotides (dNTP/NTP) for incorporation into nascent DNA/RNA and inhibit replication by preventing subsequent primer extension. To date, an integrated mathematical model that could allow th...
Guardado en:
Autores principales: | Max von Kleist, Philipp Metzner, Roland Marquet, Christof Schütte |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5aaee68234c7490a82b0e8db82cfe3e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
por: Olga Rechkoblit, et al.
Publicado: (2018) -
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase
por: Robert P. Hayes, et al.
Publicado: (2021) -
Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle
por: Zhang C, et al.
Publicado: (2020) -
Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers
por: Han Chen, et al.
Publicado: (2021) -
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
por: Salvatore Ferla, et al.
Publicado: (2018)